I’m split on when uplisting will occur. With the SP in the $3 range, CYDY would need an additional raise to meet NASDAQ requirements per MM during the last CC. MM said they prefer to raise funds at higher levels which sounds like CYDY won’t raise money at the $3 level (Fife raise will changed if this happens). Maybe this can get waived? If not, I feel CYDY will wait for interim results for a possible SP pop (the trial is halted for efficacy) and then the funding won’t be needed. If the SP doesn’t pop, I’m not sure what they’ll do. NP has never been in a rush to uplist so maybe we okay the waiting game again.